ArticleBreast cancer research and treatment2022

Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D).

Noam Pondé et al.PubMed ↗Publisher ↗

No numbers read from the abstract.